Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Follow-up of Thalidomide Maintenance in MCL/NHL
NCT02507336Phase 2Completed
- Sponsor
- University of Miami
- Start
- Nov 2015
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in mantle cell lymphoma (MCL), non-Hodgkin lymphoma (NHL), sponsored by University of Miami. Started Nov 2015; status: completed.
02
Drugs
thalidomide
03
Conditions
mantle cell lymphoma (MCL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT02507336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02507336.